Drugs / Huanglian
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00014378 | Oct 2000 → Dec 2007 | cancer of unknown primary site | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Huang Lian | “The Chinese herb Huang Lian contains ingredients that may slow the growth of cancer cells.” NCT00014378 ↗ |
| Known as | Coptis chinesis | “Chinese Herb Huanglian (Coptis chinesis)” NCT00014378 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The Chinese herb Huang Lian contains ingredients that may slow the growth of cancer cells.” NCT00014378 ↗ |
| Route | Oral | “Patients receive oral Huang Lian (Chinese herb) 4 times daily.” NCT00014378 ↗ |